000931 logo

Beijing Centergate Technologies (holding) Co., Ltd. Stock Price

SZSE:000931 Community·CN¥3.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

000931 Share Price Performance

CN¥0
-5.54 (-100.00%)
CN¥0
-5.54 (-100.00%)
Price CN¥0

000931 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

2 Risks
0 Rewards

Beijing Centergate Technologies (holding) Co., Ltd. Key Details

CN¥2.3b

Revenue

CN¥1.0b

Cost of Revenue

CN¥1.3b

Gross Profit

CN¥1.3b

Other Expenses

CN¥15.9m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 22, 2026
0.021
55.73%
0.69%
39.6%
View Full Analysis

About 000931

Founded
1999
Employees
2267
CEO
Zhanjun Hou
WebsiteView website
www.centek.com.cn

Beijing Centergate Technologies (holding) Co., Ltd. engages in the production and sale of topical reagents, tablets, injections in China. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Naltrexone Hydrochloride tablets and injections to block the pharmacological effects of exogenous opioids; Acetaminophen and oxycodone tablets and injections for the treatment of moderate to severe pain; tramadol hydrochloride tablets and injections to treat pain in adults; aprolol hydrochloride for the treatment of hypertension, angina pectoris, tachycardia-induced arrhythmia, and tremor; buspirone hydrochloride tablets to treat various anxiety disorders; oxycodone hydrochloride extended-release tablets; and Ambroxol hydrochloride injection for the treatment of acute exacerbations of chronic bronchitis, wheezing bronchitis, and bronchial asthma. It also provides Febuxostat tablets for the treatment of hyperuricemia; Bromhexine Hydrochloride injection to treat asthma, bronchiectasis, and silicosis; Metoprolol succinate raw material; Bisoprolol Amlodipine tablets for hypertension; Sitagliptin/Metformin tablets are used for type 2 diabetes patients; Bisoprolol fumarate tablets for the treatment of hypertension, coronary, and artery diseases; and Tropanestone mesylate injection for the treatment of nausea and vomiting. In addition, the company offers Sildenafil lozenges, Benzyl nonyl hydrochloride tablets, Oxycodone Hydrochloride injection, Bifonazole cream, Huperzine A tablets, Wujia Biochemical capsules, Lactobacillus tablets, Tramadol acetaminophen tablets, Tramadol hydrochloride raw material, Clindamycin phosphate to treat bacterial vaginosis, Piracetam injection, Acanthopanax senticosus, Benidipine Hydrochloride for the treatment of hypertension and angina pectoris, Glipizide Dispersible tablets, and Compound Pancreatic Enzyme powders. Beijing Centergate Technologies (holding) Co., Ltd. was founded in 1999 and is based in Beijing, China.

Recent 000931 News & Updates

Recent updates

No updates